Collegium Pharmaceutical, Inc. COLL Current portion of mortgage and loans payable
Current portion of mortgage and loans payable at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LoansPayableCurrent.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s current portion of mortgage and loans payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s current portion of mortgage and loans payable?
- Collegium Pharmaceutical, Inc. (COLL) reported current portion of mortgage and loans payable of $32.63M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s current portion of mortgage and loans payable changed year-over-year?
- Collegium Pharmaceutical, Inc.'s current portion of mortgage and loans payable decreased by 49.5% year-over-year, from $64.58M to $32.63M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s current portion of mortgage and loans payable?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s current portion of mortgage and loans payable has grown at a -9.4% compound annual growth rate (CAGR), from $47.5M to $29M.
- What does current portion of mortgage and loans payable mean?
- This represents the portion of debt obligations, including bank loans or other credit facilities, that is due for repayment within the next twelve months. It serves as a key indicator of short-term liquidity requirements and the company's ability to meet immediate debt service obligations. High levels of current debt relative to cash flow may indicate potential refinancing risks or liquidity constraints.